UniProt ID | FBX22_HUMAN | |
---|---|---|
UniProt AC | Q8NEZ5 | |
Protein Name | F-box only protein 22 | |
Gene Name | FBXO22 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 403 | |
Subcellular Localization | Cytoplasm, myofibril, sarcomere, Z line. | |
Protein Description | Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex. Promotes the proteasome-dependent degradation of key sarcomeric proteins, such as alpha-actinin (ACTN2) and filamin-C (FLNC), essential for maintenance of normal contractile function.. | |
Protein Sequence | MEPVGCCGECRGSSVDPRSTFVLSNLAEVVERVLTFLPAKALLRVACVCRLWRECVRRVLRTHRSVTWISAGLAEAGHLEGHCLVRVVAEELENVRILPHTVLYMADSETFISLEECRGHKRARKRTSMETALALEKLFPKQCQVLGIVTPGIVVTPMGSGSNRPQEIEIGESGFALLFPQIEGIKIQPFHFIKDPKNLTLERHQLTEVGLLDNPELRVVLVFGYNCCKVGASNYLQQVVSTFSDMNIILAGGQVDNLSSLTSEKNPLDIDASGVVGLSFSGHRIQSATVLLNEDVSDEKTAEAAMQRLKAANIPEHNTIGFMFACVGRGFQYYRAKGNVEADAFRKFFPSVPLFGFFGNGEIGCDRIVTGNFILRKCNEVKDDDLFHSYTTIMALIHLGSSK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEPVGCCG -------CCCCCCCC | 13.66 | 22223895 | |
40 | Acetylation | VLTFLPAKALLRVAC HHHHCCHHHHHHHHH | 37.31 | 25953088 | |
40 | Ubiquitination | VLTFLPAKALLRVAC HHHHCCHHHHHHHHH | 37.31 | 23000965 | |
40 (in isoform 1) | Ubiquitination | - | 37.31 | 21890473 | |
40 (in isoform 3) | Ubiquitination | - | 37.31 | 21890473 | |
104 | Phosphorylation | ILPHTVLYMADSETF ECCCEEEEEECCCCE | 5.97 | 18452278 | |
108 | Phosphorylation | TVLYMADSETFISLE EEEEEECCCCEECHH | 29.06 | 28122231 | |
110 | Phosphorylation | LYMADSETFISLEEC EEEECCCCEECHHHH | 30.16 | 28122231 | |
113 | Phosphorylation | ADSETFISLEECRGH ECCCCEECHHHHCCC | 26.07 | 28122231 | |
127 | Phosphorylation | HKRARKRTSMETALA CCHHHHHCCHHHHHH | 35.15 | 25159151 | |
128 | Phosphorylation | KRARKRTSMETALAL CHHHHHCCHHHHHHH | 20.75 | 21815630 | |
129 | Sulfoxidation | RARKRTSMETALALE HHHHHCCHHHHHHHH | 5.40 | 21406390 | |
131 | Phosphorylation | RKRTSMETALALEKL HHHCCHHHHHHHHHH | 20.52 | 27251275 | |
137 | Ubiquitination | ETALALEKLFPKQCQ HHHHHHHHHCHHHCC | 57.17 | 29967540 | |
194 | Ubiquitination | IQPFHFIKDPKNLTL EECEEEECCCCCCEE | 68.01 | 19608861 | |
194 | Acetylation | IQPFHFIKDPKNLTL EECEEEECCCCCCEE | 68.01 | 19608861 | |
196 | Ubiquitination | PFHFIKDPKNLTLER CEEEECCCCCCEEEE | 23.56 | 22817900 | |
196 (in isoform 2) | Ubiquitination | - | 23.56 | 21906983 | |
197 | Ubiquitination | FHFIKDPKNLTLERH EEEECCCCCCEEEEE | 74.79 | 33845483 | |
233 | Ubiquitination | NCCKVGASNYLQQVV CHHHCCHHHHHHHHH | 21.78 | 24816145 | |
300 | Ubiquitination | NEDVSDEKTAEAAMQ CCCCCCHHHHHHHHH | 59.01 | 22817900 | |
300 (in isoform 1) | Ubiquitination | - | 59.01 | 21890473 | |
337 | Ubiquitination | GFQYYRAKGNVEADA CCHHEEECCCCCHHH | 41.86 | 33845483 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FBX22_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FBX22_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FBX22_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CUL1_HUMAN | CUL1 | physical | 22268729 | |
SKP1_HUMAN | SKP1 | physical | 17463251 | |
SKP1_HUMAN | SKP1 | physical | 26496610 | |
NCOR2_HUMAN | NCOR2 | physical | 26496610 | |
KLF4_HUMAN | KLF4 | physical | 26087183 | |
SKP1_HUMAN | SKP1 | physical | 26087183 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-194, AND MASS SPECTROMETRY. |